Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Waitlist-controlled Trial to Evaluate of the Effectiveness of Immediate Treatment Compared to Deferred Treatment With the Fisher Wallace Stimulator FW-200 Device in First Responders With Self-reported Anxiety

NCT07093736 is registered in ClinicalTrials.gov with Fisher Wallace Laboratories as lead sponsor.

NCT NCT07093736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Waitlist-controlled Trial to Evaluate of the Effectiveness of Immediate Treatment Compared to Deferred Treatment With the Fisher Wallace Stimulator FW-200 Device in First Responders With Self-reported Anxiety
Lead sponsor
Fisher Wallace Laboratories
Phase
Not applicable
Overall status
Completed
Start date
July 6, 2021
Completion date
May 11, 2023
Enrollment
220 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety